Anaphylaxis after mosquito bite is rare, but life threatening. No approved preventive therapy is available to date, but omalizumab could be a promising therapeutic option for reducing risk and improving quality of life in these patients.
Keywords: anaphylaxis; mosquito allergy; omalizumab.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.